EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Prognostic and recurrence implications of subdividing WHO grade 2 pancreatic neuroendocrine tumors at a 10% Ki-67 threshold

Go-Won Choi, Inhyuck Lee, Younsoo Seo, Youngmin Han, Yoon Soo Chae, Hye-Sol Jung, Young Jae Cho, Wooil Kwon, Jin-Young Jang, Joon Seong Park

Pancreatology · 2026

DOI: 10.1016/j.pan.2026.01.079 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pancreatology, 2026. Verfasst von Go-Won Choi und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery and Cancer Research Institute, Seoul National University College of Medicine, 101 Daehak-ro, Jongno-gu, Seoul, Republic of Kore…. Hauptthemen laut MEDLINE: Ki-67 Antigen, Pancreatic Neoplasms, Neuroendocrine Tumors. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 16 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Ministry of Health and Welfare, Korea Health Industry Development Institute, Korea National Institute of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Although World Health Organization (WHO) grade 1 and 2 pancreatic neuroendocrine tumors (pNETs) are generally regarded as indolent, substantial biological heterogeneity exists, particularly within grade 2 (G2) tumors. This study evaluated whether subdividing G2 pNETs using new Ki-67 threshold improves postoperative risk stratification following curative resection. METHODS: We retrospectively analyzed consecutive adults who underwent pancreatectomy for pNETs between 2010 and 2022. Tumors were classified as G1 ( 2, lymph node positivity, mitotic count >2, and grade subtype were independently associated with worse DFS, while grade subtype remained the only independent predictor of OS. CONCLUSION: Subclassification of WHO G2 pNETs using a 10% Ki-67 threshold enhances postoperative risk stratification. When integrated with established pathological factors, this approach may better identify patients at increased risk of recurrence following curative resection.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Ki-67 AntigenPancreatic NeoplasmsNeuroendocrine TumorsHumansFemaleRetrospective StudiesNeoplasm Recurrence, LocalPrognosisMiddle AgedMaleAgedNeoplasm GradingAdultPancreatectomyDisease-Free SurvivalWorld Health Organization

Stichwörter der Autor:innen

GradeKi-67 proliferative indexPancreatic neuroendocrine tumorPrognosis

Substanzen

Ki-67 Antigen

Autor:innen und Institutionen

  • Department of Surgery and Cancer Research Institute, Seoul National University College of Medicine, 101 Daehak-ro, Jongno-gu, Seoul, Republic of Korea.
  • Department of Surgery and Cancer Research Institute, Seoul National University College of Medicine, 101 Daehak-ro, Jongno-gu, Seoul, Republic of Korea. Electronic address: jspark330@snu.ac.kr.

Förderung

  • Ministry of Health and Welfare
  • Korea Health Industry Development Institute
  • Korea National Institute of Health

Zitieren

APA

Choi, G. W., Lee, I., Seo, Y., Han, Y., Chae, Y. S., Jung, H. S., Cho, Y. J., Kwon, W., Jang, J. Y., & Park, J. S. (2026). Prognostic and recurrence implications of subdividing WHO grade 2 pancreatic neuroendocrine tumors at a 10% Ki-67 threshold. Pancreatology. https://doi.org/10.1016/j.pan.2026.01.079

Vancouver

Choi GW, Lee I, Seo Y, Han Y, Chae YS, Jung HS, et al. Prognostic and recurrence implications of subdividing WHO grade 2 pancreatic neuroendocrine tumors at a 10% Ki-67 threshold. Pancreatology. 2026. doi:10.1016/j.pan.2026.01.079

BibTeX
@article{Choi2026,
  author = {Choi, Go-Won and Lee, Inhyuck and Seo, Younsoo and Han, Youngmin and Chae, Yoon Soo and Jung, Hye-Sol and Cho, Young Jae and Kwon, Wooil and Jang, Jin-Young and Park, Joon Seong},
  title = {Prognostic and recurrence implications of subdividing WHO grade 2 pancreatic neuroendocrine tumors at a 10% Ki-67 threshold},
  journal = {Pancreatology},
  year = {2026},
  doi = {10.1016/j.pan.2026.01.079}
}
Kostenlos starten →